Next-Generation Sequencing (NGS)

Kalorama’s 2026 report analyzes the global mass spectrometry market in IVD, forecasting nearly double growth by 2030 across instruments, IVD kits, and clinical diagnostic applications.

As next-generation sequencing expands into clinical diagnostics and precision oncology, upstream sample preparation is under growing scrutiny. This Kalorama report sizes the global NGS library preparation and target enrichment market through 2030, with competitive share estimates and in-depth profiles of 13 leading suppliers including Illumina, Twist Bioscience, IDT, and Thermo Fisher.

The global in vitro diagnostics (IVD) market is entering a period of measured but positive growth, shaped less by disruptive platform launches and more by strategic portfolio realignment, digital integration, and selective innovation. Kalorama Information’s 19th Edition of The Worldwide Market for In Vitro Diagnostic (IVD) Tests examines how industry participants are navigating competitive pressures, cost constraints,…

The next era of healthcare is here—and it’s powered by companion diagnostics (CDx). These essential tools are redefining how diseases are detected, monitored, and treated by aligning diagnostics directly with therapeutic decision-making. Kalorama Information’s Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition provides an in-depth, data-driven analysis of this rapidly evolving market—one…

Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 18th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2025 to 2030, and essential insights needed to understand the IVD market in its entirety. With…

Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With…

Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023…

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

Kalorama Information presents the latest insights and comprehensive analysis in its new report, The Market for RNA Sequencing, 3rd Edition. This essential market research report delves into the rapidly evolving RNA sequencing sector, highlighting the remarkable advancements and applications that promise to revolutionize healthcare.

 

Overview:

In the past decade, the sequencing market has witnessed…

Kalorama Information presents the 16th edition of The Worldwide Market for In Vitro Diagnostic Tests, the most comprehensive and reliable report on the global IVD industry. Essential for anyone involved in the IVD sector, this report offers crucial insights, reliable estimates, and real-world forecasts to help you make well-informed decisions. It’s the most trusted and…

Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution identification of cell types and markers, and understanding differentiation pathways in developmental and systems biology.

Explore the dynamic market…

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas.  In recent years, the use of…